Different Calcium Requirements for Low Iodine Diet (LID) Induced and Developmental Growth of the Rat Thyroid: Evidence from in Culture Experiments

  • Helene Triantaphyllidis


In vivo, in post-embryonic life, most mammalian cells are growth arrested. Considered a few years ago as the main target of extracellular Ca2+ on the cell cycle, initiation to division is not believed to be extracellular Ca2+-dependent (1). Initiation covers one quarter to one third of G1, the phase of the cycle that precedes DNA synthesis (2). Presence of the cation is required in the incubating media over the second half of G1 (3). Once initiation is accomplished, each phase of the cycle proceeds within a determined time and, if adequate Ca2+ concentration is not provided over the Ca2+sensitive period, initiation vanishes. No DNA synthesis at all occurred with BALBc/3T3 mouse cells, initiated in very low Ca2+, when mMolar Ca2+ was given past three lengths of G1 (3). That in vivo hypocalcemia suppressed cell proliferation in some instances and not in others (4) could be interpreted in two different ways: either that Ca2+ requirements for cell division are different for divisions induced by different mitogens, since it was shown that epidermal growth factor (EGF) reduced Ca2+ requirements for growth of the normal epithelial cell line NP-2s by two orders of magnitude (5); or that alteration of other parameters, such as permeability of the plasma membrane (PM) to the ion and/or cell geometry, affected the rate of Ca2+ collection.


Thyroid Cell Cell Coat Developmental Growth Thyroid Cell Line Thyroid Research 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hesketh TR, Smith GA, Houslay MD, et al. Nature 267: 490, 1977.PubMedCrossRefGoogle Scholar
  2. 2.
    Novogrodsky A and Katchalski E. BBA 228: 579, 1971.PubMedCrossRefGoogle Scholar
  3. 3.
    Boynton AL, Whitfield JF, and Isaaks RJ. In Vitro 12: 120, 1976.PubMedCrossRefGoogle Scholar
  4. 4.
    Triantaphyllidis H. In M Andreoli, F Monaco, and J Robbins (eds), Advances in Thyroid Neoplasia, Field Educational Italia, Rome and Chicago, 1981, p 109.Google Scholar
  5. 5.
    Lechner JF and Kaighn ME. Exp Cell Res 121: 432, 1979.PubMedCrossRefGoogle Scholar
  6. 6.
    Triantaphyllidis H. Ann Endocrinol (Paris) 40: 385, 1979.Google Scholar
  7. 7.
    Triantaphyllidis H and Guichard C. In SR Stockight and S Nagataki (eds), Thyroid Research VIII, Pergamon Press, London and New York, 1980, p 149.Google Scholar
  8. 8.
    Meishrich ML, Meyn RE, and Barlogie B. Exp Cell Res 105: 169, 1977.CrossRefGoogle Scholar
  9. 9.
    Westermark K and Westermark B. Exp Cell Res 138: 47, 1982.PubMedCrossRefGoogle Scholar
  10. 10.
    Ambesi-Impiombato FS, Parks LAM, and Coon HG. PNAS 77: 3455, 1980.PubMedCrossRefGoogle Scholar
  11. 11.
    Triantaphyllidis H, Tramontano D, and Ingbar SH. In preparation.Google Scholar
  12. 12.
    Douglas WW and Rubin RP. J Physiol (London) 159: 40, 1961.Google Scholar
  13. 13.
    Borle AB. J Cell Biol 36: 567, 1968.PubMedCrossRefGoogle Scholar
  14. 14.
    Triantaphyllidis H. In N Ui, K Torizuka, S Nagataki, et al. (eds), Current Problems in Thyroid Research, Excerpta Medica, AmsterdamLondon-Princeton, 1982, p 69.Google Scholar
  15. 15.
    Hachiya T, Miyazaki T, Kaimasu I, et al. In J Robbins and LE Braverman (eds), Thyroid Research, Excerpta Medica - American Elsevier, Amsterdam-Oxford-New York, 1976, p 89.Google Scholar
  16. 16.
    Tupper JT, Del Rosso M, Hazelton B, et al. J Cell Physiol 95: 71, 1978.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1986

Authors and Affiliations

  • Helene Triantaphyllidis
    • 1
  1. 1.Laboratoire Regulations IoniquesUER Biomedicale Saints-PeresParisFrance

Personalised recommendations